companydata.dkcompanydata.dk

TRY MEDICS ApS: Financial statements 2024

CVR: 36089776

Source: annual report 2024, Danish Business Authority

01/01/202431/12/2024

TRY MEDICS ApS (CVR 36089776) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 2,940,173 and a net result of DKK 1,590,833 compared with DKK 464,142 the year before. That is an increase of 158.8% compared with the year before. Equity in the 2024 report amounted to DKK 2,599,707. The solvency ratio was 38.9%. The company had 2 employees in the financial year.

Gross Profit
DKK 2,940,173
Profit/Loss
DKK 1,590,833
Equity
DKK 2,599,707
Total Assets
DKK 6,684,583
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-2.9 mio.1.6 mio.2.6 mio.2
2023-1.1 mio.464 t.1.5 mio.1
2022-3.2 mio.2 mio.2.5 mio.1
2021-850 t.209 t.492 t.1
2020-487 t.-305 t.283 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

TRY MEDICS ApS: The 2023 annual report is outJul 2, 2024

TRY MEDICS ApS has published its annual report for 2023. Gross profit came to DKK 1,136,160, and the net result was DKK 464,142.

About TRY MEDICS ApS

TRY MEDICS ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2014. The company is registered under the industry Rejsearrangørers aktiviteter. The management consists of Oliver Andersen. The company is owned by SONNY RASMUSSEN CONSULTING ApS and OLIGATER HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 4,540,845 and a net result of DKK 2,203,477 compared with DKK 1,590,833 the year before. Equity in the 2025 report amounted to DKK 3,303,184.

Source: annual report 2025, Danish Business Authority